Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/2014
10/02/2014US20140296490 Highly galactosylated antibodies
10/02/2014US20140296489 Protein Production Method
10/02/2014US20140296488 Anti-notch nrr antibodies and methods using same
10/02/2014US20140296139 Mitochondrial-derived peptide mots3 regulates metabolism and cell survival
10/02/2014US20140296101 Secreted proteins and uses thereof
10/02/2014US20140295544 Fluorescent proteins with increased activity in cells
10/02/2014US20140295521 Method for reducing the immune response to a biologically active protein
10/02/2014US20140295502 cDNA Synthesis Improvements
10/02/2014US20140295495 Methods of Preventing and Removing Trisulfide Bonds
10/02/2014US20140295494 HIGH AFFINITY, ANTI-HUMAN IgE ANTIBODIES
10/02/2014US20140295489 Organic compounds
10/02/2014US20140295469 In Vitro Assessment of Cardiovascular Events by Assay for Neo-Eptitopes of Titin Protein
10/02/2014US20140295463 ELISA Detection of Urine DEK to Predict and Diagnose Bladder Cancer in Humans
10/02/2014US20140295462 RBM3 Protein in Colorectal Cancer Prognostics
10/02/2014US20140295457 Gene cluster for biosynthesis of griselimycin and methylgriselimycin
10/02/2014US20140295455 Antibody for detecting epithelial ovarian cancer marker and method for diagnosing epithelial ovarian cancer
10/02/2014US20140295409 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences
10/02/2014US20140294930 STREPTOCOCCAL GlcNAc-LACKING GLYCOPOLYPEPTIDES, CELL WALL CARBOHYDRATES, STREPTOCOCCUS VACCINES, AND METHODS FOR MAKING AND USING THEM
10/02/2014US20140294891 Microorganisms for therapy
10/02/2014US20140294872 Methods of preparing lyophilized spherical-shaped pellets of biological materials
10/02/2014US20140294866 Uses of Myostatin Antagonists
10/02/2014US20140294863 Serum albumin binding peptides for tumor targeting
10/02/2014US20140294860 Means and methods for treating and/or preventing natural ahr ligand-dependent cancer
10/02/2014US20140294858 Subcutaneous administration of anti-hepatitis b antibodies
10/02/2014US20140294857 Methods of obtaining a specific binding member that binds eotaxin
10/02/2014US20140294854 Target directed to adipocytes, methods and assays for treatment of obesity
10/02/2014US20140294853 Antagonistic dr3 ligands
10/02/2014US20140294852 Monoclonal antibodies to programmed death 1 (pd-1)
10/02/2014US20140294850 Early childhood membranous nephropathy due to cationic bovine serum albumin
10/02/2014US20140294848 Novel Targets for Regulation of Angiogenesis
10/02/2014US20140294847 Biological materials related to c-met
10/02/2014US20140294846 Function and regulation of adamts-1
10/02/2014US20140294845 Anti-pleiotrophin antibodies and methods of use thereof
10/02/2014US20140294844 Prion protein antibodies for the treatment of alzheimer's disease
10/02/2014US20140294842 Assays, Methods and Means
10/02/2014US20140294841 T cell receptor-like antibodies specific for a wti peptide presented by hla-a2
10/02/2014US20140294839 Methylated Peptides Derived from Tau Protein and Their Antibodies for Diagnosis and Therapy of Alzheimer's Disease
10/02/2014US20140294838 Bispecific anti-cmet/anti-her2 antibodies
10/02/2014US20140294837 Fusion protein comprising anti-c-met antibody and vegf-binding fragment
10/02/2014US20140294836 Targeting regulatory t cells with heterodimeric proteins
10/02/2014US20140294835 Novel heterodimeric proteins
10/02/2014US20140294834 Tandem fc bispecific antibodies
10/02/2014US20140294833 Novel heterodimeric proteins
10/02/2014US20140294832 Monoclonal antibodies against tissue factor pathway inhibitor (tfpi)
10/02/2014US20140294831 Methods of treating a tauopathy
10/02/2014US20140294829 Anti-ngf antibodies for the treatment of various disorders
10/02/2014US20140294828 Alphabodies specifically binding to viral proteins and methods for producing the same
10/02/2014US20140294827 Fully Human Antibodies that Bind to VEGFR2
10/02/2014US20140294826 Methods and compositions with a recombinant neutralizing binding protein for treating toxin exposure
10/02/2014US20140294825 Hybrid constant regions
10/02/2014US20140294824 Antibodies that bind to ox40 and their uses
10/02/2014US20140294823 Heterodimeric proteins
10/02/2014US20140294822 Methods and compositions for increasing arylsulfatase a activity in the cns
10/02/2014US20140294820 Fibroblast growth factor receptor inhibition for the treatment of disease
10/02/2014US20140294819 Canine/feline cd20 binding epitope and compositions for binding thereto
10/02/2014US20140294818 Pgam1 inhibitors and methods related thereto
10/02/2014US20140294817 POLYPEPTIDES COMPRISING Fc FRAGMENTS OF IMMUNOGLOBULIN G (IgG) AND METHODS OF USING THE SAME
10/02/2014US20140294815 Caninised tumour necrosis factor antibodies and methods of using the same
10/02/2014US20140294814 Humanized and affinity-matured anti-c-met antibody and uses thereof
10/02/2014US20140294813 TNF Binding Proteins
10/02/2014US20140294812 Fc variants that improve fcrn binding and/or increase antibody half-life
10/02/2014US20140294810 Immunoglobulin variants and uses thereof
10/02/2014US20140294809 Anti-Alpha(v)Beta(6) Antibodies and Uses Thereof
10/02/2014US20140294804 Methods of treating pain
10/02/2014US20140294768 Responsiveness to angiogenesis inhibitors
10/02/2014US20140294765 Lsr antibodies, and uses thereof for treatment of cancer
10/02/2014US20140294760 Novel cell and therapeutical and diagnostical methods based thereon
10/02/2014US20140294759 Targeting regulatory t cells with heterodimeric proteins
10/02/2014US20140294758 Light chain immunoglobulin fusion proteins and methods of use thereof
10/02/2014US20140294731 Phosphospecific antibodies recognising tau
10/02/2014US20140294726 Methods for diagnosing and treating alzheimer's disease by administering an anti-angiogenic agent
10/02/2014US20140294722 Anti-Pancreatic Cancer Antibodies
10/01/2014EP2784092A2 Fusion protein comprising anti-c-Met antibody and VEGF-binding fragment
10/01/2014EP2784091A1 Bispecific anti-cMet/anti-Her2 antibodies
10/01/2014EP2784090A1 Compositions for the treatment of systemic onset juvenile idiopathic arthritis
10/01/2014EP2784089A1 Improved mammalian expression vectors and uses thereof
10/01/2014EP2784088A2 Monoclonal antibodies specific for the m2-1 antigen of respiratory syncytial virus (rsv)
10/01/2014EP2784084A1 IL-17 A/F heterologous polypeptides and therapeutics uses thereof
10/01/2014EP2784080A1 Peptide-hinge-free flexible antibody-like molecule
10/01/2014EP2783701A2 Extended treatment of multiple sclerosis
10/01/2014EP2783014A1 Methods of treating psoriatic arthritis (psa) using il-17 antagonists and psa response or non- response alleles
10/01/2014EP2782936A1 Monoclonal antibody for the detection of snap/clip tag
10/01/2014EP2782935A1 Anti-cd98 antibodies and methods of use thereof
10/01/2014EP2782934A1 Anti-fgfr2 antibodies and uses thereof
10/01/2014EP2782933A1 Methods and pharmaceutical compositions for reducing airway hyperresponse
10/01/2014EP2782932A1 Purification of anti-c-met antibodies
10/01/2014EP2782931A1 Cd40l expressing mammalian cells and their use
10/01/2014EP2782928A1 Mutations of histone proteins associated with proliferative disorders
10/01/2014EP2782600A1 Combination therapy using anti - cd20 antibody and human il-15
10/01/2014EP2782599A2 Administration of alpha4beta7 hetero-dimer-specific antibody
09/2014
09/30/2014US8846952 Detection or quantification of desirable target molecules, novel dyes, composite dyes, and oligonucleotides or polynucleotides comprising such dyes
09/30/2014US8846876 Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
09/30/2014US8846874 IgG Fc fragment for a drug carrier and method for the preparation thereof
09/30/2014US8846873 Antibodies directed to GPNMB and uses thereof
09/30/2014US8846872 Monoclonal antibodies and diagnostic uses thereof
09/30/2014US8846871 Anti-Notch1 NRR antibodies
09/30/2014US8846870 Anti-HS6ST2 antibodies and uses thereof
09/30/2014US8846869 Mutant protein capable of binding specifically and quickly to troponin I derived from human myocardium
09/30/2014US8846868 Anti-AREG/HB-EGF antibodies and treatment
09/30/2014US8846867 Isolation of anti-desmoglein 1 antibodies by phage display of pemphigus foliaceus autoantibodies
1 ... 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 ... 1494